Scale molecular variant interpretation without expanding staff, by Sheryl Elkin, PhD @Labroots
Scale molecular variant interpretation without expanding staff, by Sheryl Elkin, PhD  @Labroots
Uploaded October 2026 | Updated November 2026, 5 hours ago
Molecular oncology laboratories face mounting pressure as expanding sequencing capabilities produce increasingly complex variant profiles that demand extensive interpretation. At the same time, growing testing volumes and limited specialized staff create bottlenecks in variant curation, evidence review and report generation. Ensuring accurate, consistent reports while keeping pace with evolving guidelines and delivering timely results has become a major operational challenge.

That’s why leading laboratories rely on QCI Precision Insights (formerly N-of-One), a professional clinical variant interpretation service built for molecular oncology:

- Trusted, reliable expertise: A dedicated team of PhD scientists and consulting oncologists transforms complex biomarker data into clear, clinically actionable insights—complete with report-ready content for physicians.
- Grounded in real-world evidence: Interpretations are supported by FDA drug labels, practice guidelines, clinical trials, and peer-reviewed literature to ensure comprehensive clinical context.
- Confidence for physicians, better care for patients: Deliver the insights oncologists need to make faster, more informed treatment decisions—helping patients receive the right therapy at the right time.
Scale molecular variant interpretation without expanding staff, by Sheryl Elkin, PhDTTutorial: How to work with UK Biobank proteomic dataPrecision & Efficiency Multiplexing in qPCR for Assay DevelopmentMonitoring and evaluating CAR T cells in patient cohortsNavigating Real-World Challenges in Blood Gas Specimen Collection: A Collaborative Journey to...Illumina Innovation: The making of XLEAP-SBS™ Chemistry from concept to integrationMycoplasma pneumoniae in the post COVID-19 era: Diagnostic challenges and rising macrolide..Keynote Presentation: Selecting Targeted Cancer Therapies and Clinical Trials with Computational...Human-on-a-Chip for Translational PK/PD and Disease Modeling: Cardiac Ischemia, a Patient...Precision in Practice: Managing Indeterminate TB Testing with Quality SystemsUnlock Cell Therapy Potential with Customizable Cell Isolation and Enhanced T cell Activation...Lessons from the Classroom Using ELNs to Train the Next Generation of Scientists
Labroots |

Scale molecular variant interpretation without expanding staff, by Sheryl Elkin, PhD

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER